Stocks · Health care · Pharmaceutical Preparations

IONIS PHARMACEUTICALS INC

IONS Clue Score40
United States Fiscal year ends December CIK 0000874015 Results filed 29 Jul 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Holly B. Kordasiewicz
7 Jul 2026
EVP, Chief Development Officer
Sold on a plan
362
$84.30
$30.52K
C Frank Bennett
7 Jul 2026
EVP, Chief Scientific Officer
Sold on a plan indirect
15,000
$85.46
$1.28M
C Frank Bennett
7 Jul 2026
EVP, Chief Scientific Officer
Sold on a plan
5,536
$83.58
$462.69K
Patrick R. O'Neil
26 Jun 2026
EVP CLO & General Counsel
Sold on a plan
3,069
$80.00
$245.52K
Eric Swayze
25 Jun 2026
EVP Research
Sold on a plan
10,602
$79.18
$839.49K
Joseph Baroldi
28 Apr 2026
EVP, Chief Business Officer
Sold on a plan
1,626
$71.79
$116.73K
B Lynne Parshall
15 Apr 2026
Director
Sold on a plan
534
$76.97
$41.10K
B Lynne Parshall
15 Apr 2026
Director
Sold on a plan
4,466
$76.19
$340.26K
Shannon L. Devers
2 Apr 2026
EVP, Chief Human Resources Ofc
Sold on a plan
6,193
$74.05
$458.61K
Eugene Schneider
19 Mar 2026
EVP, Chf Clinical Develop Ofcr
Sold on a plan
5,812
$70.97
$412.49K
Elizabeth L Hougen
17 Mar 2026
EVP, Finance & CFO
Sold on a plan
10,172
$73.21
$744.66K
Patrick R. O'Neil
9 Mar 2026
EVP CLO & General Counsel
Sold on a plan
10,148
$75.25
$763.66K
Eric Swayze
13 Feb 2026
EVP Research
Sold on a plan
6,207
$82.07
$509.40K
Eric Swayze
13 Feb 2026
EVP Research
Sold on a plan
9,435
$81.56
$769.51K
B Lynne Parshall
11 Feb 2026
Director
Sold on a plan
5,000
$82.72
$413.59K
Brett P Monia
6 Feb 2026
Chief Executive Officer
Sold on a plan
29,430
$85.79
$2.52M
Shannon L. Devers
22 Jan 2026
EVP, Chief Human Resources Ofc
Sold on a plan
3,977
$81.34
$323.49K
Joseph H Wender
1 Dec 2025
Director
Sold on a plan indirect
7,429
$81.23
$603.49K
Joseph H Wender
1 Dec 2025
Director
Sold on a plan indirect
20,571
$80.67
$1.66M
Brian Birchler
6 Nov 2025
EVP, Corp and Development Ops
Sold on a plan
8,000
$76.17
$609.38K

What was left out

Form 4 filings counted 101
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 20
Sales straight out of an exercise 66
Sales at will 26
Transactions with no price 0
Shares from compensation/vesting 1,631,784
History held since 10 Oct 2006